Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testin...(ritical tasks such as abnormal patient r...)

Mercy Medical Center's integrated testing solution includes the Sysmex HST-302 automated platform -- two XE-Series automated hematology analyzers, one SP-1000i automated slide maker and stainer, MOLIS WAM, one TS-500 Tube Sorter/archiver, Return Line and the Bio-Rad VARIANT II TURBO Link A1C testing system. "Our A1C method uses HPLC technology, the industry's gold standard for A1C testing. In addition to diabetes monitoring, our method detects some common hemoglobin abnormalities. This clinical information can be forwarded to the physician, adding valuable patient information," said Scott Joksch, Senior Product Manager at Bio-Rad.

"In addition to enhancing its diabetic testing services, Mercy Medical Center's foresight has enabled the automation of testing and data management of 90% of tests performed on EDTA samples and automated sample management of virtually 100% of all EDTA samples (i.e. CBC, Diff, Retic, ESR and other esoteric tests)," said Nilam Patel, Sr. Product Manager, Automation Solutions, Sysmex America, Inc. "This Lavender Top Management(TM) solution by Sysmex offers clinical laboratories quality results, superior instrument and automation performance (uptime) and improved productivity, turn around times and labor utilization," added Patel.

About HbA1c

The hemoglobin A1c (A1C) blood test, which measures the amount of glucose attached to the hemoglobin in the red blood cell, is an estimate of a patient's blood glucose control during the previous three to four months.

Diabetes is a chronic condition that can increase a patient's risk for developing serious complications including heart disease and stroke, high blood pressure, blindness, kidney and nervous system diseases. Proper diabetes management can delay or even prevent the onset of complications, allowing patients to live healthier, more productive lives.

About Mercy Medical Center

Mercy
'/>"/>